Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.

512.38 3.06 −0.59%
Market cap
$6.7B
P/E
25.7×
Fwd P/E
20.4×
Dividend yield
0.49%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

24.11% 25.28% 25.60% 27.11%
Piotroski F-Score
6 6 5 5
ROA
16.43% 16.54% 15.93% 16.68%
ROIC
23.20% 23.36% 22.23% 23.46%
Return on Tangible Assets
90.77% 119.94% 161.98% 152.87%
Average Days of Receivables
31.09 26.34 30.96 26.53
Free Cash Flow per Share
25.32 22.92 27.91 24.91
Free Cash Flow
364.45 330.05 381.71 328.12
Other line items

Show all line items

Columns are period end dates